Comment from Flagship Pioneering

Summary: Flagship Pioneering, a venture creation and innovation firm, supports the FDA's Plausible Mechanism framework as a necessary step toward modernizing regulatory approaches for individualized therapies. They argue for expanding the framework's scope to include more modalities and patient populations, while requesting greater clarity on its relationship to existing pathways and operational implementation.